A study shows the 2022 H5N1 avian flu strain binds and replicates more efficiently in the human respiratory tract than previous strains. While most human cases have been mild, concerns exist about potential increased risk of human infection and transmission due to this enhanced binding. Further research is crucial to assess pandemic risk.
